Nephro Care India Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Nephro Care India Ltd is ₹ 83 as of 23 Oct 15:30 . The P/E Ratio of Nephro Care India Ltd changed from 25.4 on March 2026 to 25.4 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Nephro Care India Ltd changed from ₹ 85.32 crore on March 2026 to ₹ 85.32 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Nephro Care India Ltd for the Jun '26 is ₹ 29.41 crore as compare to the Mar '26 revenue of ₹ 27.58 crore. This represent the growth of 6.64% The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The ebitda of Nephro Care India Ltd for the Jun '26 is ₹ 3.84 crore as compare to the Mar '26 ebitda of ₹ 2.85 crore. This represent the growth of 34.74% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The net profit of Nephro Care India Ltd changed from ₹ -0.65 crore to ₹ 1.61 crore over 5 quarters. This represents a CAGR of NaN% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About Nephro Care India Ltd

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of Nephro Care India Ltd and Syngene International Ltd

Which company has a larger market capitalization, Nephro Care India Ltd or Syngene International Ltd?

Market cap of Nephro Care India Ltd is 136 Cr while Market cap of Syngene International Ltd is 14,810 Cr

What are the key factors driving the stock performance of Nephro Care India Ltd and Syngene International Ltd?

The stock performance of Nephro Care India Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nephro Care India Ltd and Syngene International Ltd?

As of October 25, 2026, the Nephro Care India Ltd stock price is INR ₹83.0. On the other hand, Syngene International Ltd stock price is INR ₹366.9.

How do dividend payouts of Nephro Care India Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Nephro Care India Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.